Doxorubicin is an anthracycline class medication used to manage and treat various types of malignancies and tumors. It has both FDA-approved and off-label indications.

**FDA Approved Indications**

- Acute lymphocytic leukemia

- Acute myelogenous leukemia

- Hodgkin lymphoma

- Non-Hodgkin lymphoma

- Bladder cancer

- Metastatic breast cancer

- Ewing sarcoma

- Metastatic neuroblastoma

- Metastatic ovarian carcinoma

- Metastatic osteogenic sarcoma

- Small cell lung cancer

- Metastatic soft tissue sarcoma

- Thyroid cancer

- Wilms tumor

**Non-FDA Approved Indications**

- Advanced endometrial carcinoma

- Metastatic hepatocellular cancer

- Multiple myeloma

- Advanced renal cell carcinoma

- Thymomas and thymic malignancies

- Uterine sarcoma

- Waldenstrom macroglobulinemia